PMID: 7517330Mar 1, 1994Paper

Evidence that nitric oxide is an endogenous antiangiogenic mediator

British Journal of Pharmacology
E Pipili-SynetosM E Maragoudakis

Abstract

1. The involvement of nitric oxide (NO) in the regulation of angiogenesis was examined in the in vivo system of the chorioallantoic membrane (CAM) of the chick embryo and in the matrigel tube formation assay. 2. Sodium nitroprusside (SNP) (0.37-28 nmol/disc), which releases NO spontaneously, caused a dose-dependent inhibition of angiogenesis in the CAM in vivo and reversed completely the angiogenic effects of alpha-thrombin (6.7 nmol/disc) and the protein kinase C (PKC) activator 4-beta-phorbol-12-myristate-13-acetate (PMA) (0.97 nmol/disc). In addition, SNP (28 x 10(-6) M) stimulated the release of guanosine 3'-5'-cyclic monophosphate (cyclic GMP) from the CAM in vitro. 3. In the matrigel tube formation assay, an in vitro assay of angiogenesis, both SNP (1-3 x 10(-6) M) and the cell permeable cyclic GMP analogue, Br-cGMP (0.3-1.0 x 10(-3) M) reduced tube formation. 4. The inhibitors of NO synthase, NG-monomethyl-L-arginine (L-NMMA) (3.8-102 nmol/disc) and NG-nitro-L-arginine methylester (L-NAME) (1.3-34.2 nmol/disc) stimulated angiogenesis in the CAM in vivo, in a dose-dependent fashion. D-NMMA and D-NAME on the other hand had no effect on angiogenesis in this system. 5. L-Arginine (10.9 nmol/disc), although it had a modest an...Continue Reading

References

Aug 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·W P ArnoldF Murad
May 1, 1992·Scientific American·S H Snyder, D S Bredt
Sep 4, 1992·Cell·C J Lowenstein, S H Snyder
Sep 24, 1991·Biochimica Et Biophysica Acta·M G DoniA Alexandre
Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M W RadomskiS Moncada
Aug 1, 1991·European Journal of Clinical Investigation·S Moncada, E A Higgs
Feb 1, 1991·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·J W FentonJ M Maraganore
Jan 1, 1988·Tissue & Cell·M E MaragoudakisM Sarmonika
Dec 15, 1989·Biochemical and Biophysical Research Communications·D C SaneY A Hannun
Feb 1, 1988·Trends in Pharmacological Sciences·C P Page
Nov 30, 1988·Biochemical and Biophysical Research Communications·J B HibbsE M Rachlin
Mar 1, 1983·Journal of Cellular Physiology·S A Harris-HookerS M Schwartz
Jul 31, 1984·Biochemical and Biophysical Research Communications·H RasmussenA Scriabine
Apr 1, 1993·British Journal of Pharmacology·E Pipili-SynetosM E Maragoudakis
Apr 1, 1993·Inflammation·D E HuT P Fan
May 1, 1993·The American Journal of Physiology·N E TsopanoglouM E Maragoudakis
Jul 1, 1993·Journal of Vascular Research·N E TsopanoglouM E Maragoudakis

❮ Previous
Next ❯

Citations

Nov 1, 1996·Journal of Cellular Biochemistry·A RayChaudhuryA B Malik
Jan 1, 1994·Microsurgery·A G StewartG Grigoriadis
May 12, 2005·Angiogenesis·Shiladitya SenguptaTai-Ping D Fan
Aug 15, 1995·European Journal of Pharmacology·C D DinesN E Cameron
Mar 19, 2003·Archives of Oral Biology·P A BrennanJ D Langdon
Jun 3, 1999·Biochemical Pharmacology·M A MedinaF Sánchez-Jiménez
Mar 18, 2000·European Journal of Pharmacology·L JiaX Young
Apr 9, 2002·Prostaglandins & Other Lipid Mediators·Chatargy S KazaBasil Rigas
Sep 7, 2000·General Pharmacology·V G ManolopoulosB Nilius
Nov 25, 1998·Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology·M GerolA RayChaudhury
Oct 11, 2002·Free Radical Biology & Medicine·Nilanjana Maulik, Dipak K Das
Apr 10, 2003·Free Radical Biology & Medicine·Keping Xie, Suyun Huang
Dec 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F BussolinoG Persico
Feb 15, 2003·Nitric Oxide : Biology and Chemistry·N P KonovalovaA M Korolev
Jul 9, 2003·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·B RigasA G Vagenakis
Feb 12, 1998·British Journal of Pharmacology·E SakkoulaM E Maragoudakis
Dec 24, 1998·British Journal of Pharmacology·E Pipili-SynetosM E Maragoudakis
Jul 17, 1998·The British Journal of Dermatology·K ShimizuI Katayama
Dec 22, 1998·The Journal of Experimental Medicine·S E PikeG Tosato
Dec 10, 2002·Antioxidants & Redox Signaling·Toyoaki Murohara, Takayuki Asahara
Oct 13, 2006·Antioxidants & Redox Signaling·Nilanjana Maulik
Mar 3, 1999·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·K Norrby
Jun 17, 1998·The Journal of Clinical Investigation·T MuroharaJ M Isner
Apr 6, 2000·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·P Collin-OsdobyP Osdoby
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·A R AminS B Abramson
Mar 29, 2002·Journal of Cellular Physiology·Akira AndoPeter A Campochiaro
Nov 27, 1998·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·G HildebrandtK R Trott
Aug 6, 2004·Free Radical Research·Christos Polytarchou, Evangelia Papadimitriou
Dec 10, 2008·Endothelium : Journal of Endothelial Cell Research·Maria FlorianSheldon Magder
Jul 31, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Stefania MerighiPier Andrea Borea

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.